Digital

Digital/ Insights/ News/ News/ Views and analysis

Considerations for Mobile Health Technology Developers: Part 2

mike.hammerton@pharmaphorum.com clinical decision support, criteria, definition, fda, guidance, medical software, mobile medical devices, Regulations 0 Comment

In Part 1 of this series, general wellness devices and mobile medical applications (MMAs) were considered. Part 2

Considerations for Mobile Health Technology Developers: Part 2

https://pharmaphorum.com/views-and-analysis/considerations-for-mobile-health-technology-developers-part-2/

Digital/ Views & Analysis/ Views and analysis

Hollywood and the Metaverse’s effect on pharma’s content

Jessica Hagen customer experience, digital, eye-tracking, metaverse, on-demand content, pharma 0 Comment

Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the

Hollywood and the Metaverse’s effect on pharma’s content

https://pharmaphorum.com/views-and-analysis/hollywood-and-the-metaverses-effect-on-pharmas-content/

Digital/ News/ News/ News/ Sales and Marketing

Babylon hires Andrew Hine to spearhead overseas expansion

Phil Taylor Babylon Health, digital, digital health, online consultation, senior management 0 Comment

UK digital health company Babylon has hired Andrew Hine to take charge of its international expansion efforts, as

Babylon hires Andrew Hine to spearhead overseas expansion

https://pharmaphorum.com/news/babylon-hires-andrew-hine-to-spearhead-overseas-expansion/

Digital/ News/ News/ News/ Patients

Digital tool cuts hospital readmissions in cirrhosis patients

Phil Taylor CirrhoCare, cirrhosis, CyberLiver, digital, digital health, hepatology 0 Comment

A digital patient monitoring tool developed by UK company CyberLiver has been given a breakthrough designation by the

Digital tool cuts hospital readmissions in cirrhosis patients

https://pharmaphorum.com/news/digital-tool-cuts-hospital-readmissions-in-cirrhosis-patients/

Digital/ Insights/ News/ Views & Analysis/ Views and analysis

Considerations for Mobile Health Technology Developers: Part 1

mike.hammerton@pharmaphorum.com CDS, clinical decision support, enforcement, fda, medical devices, mHealth, MMAs, mobile medical applications, Regulations, risk assessment 0 Comment

In Part 1 of this series, general wellness devices and mobile medical applications (MMAs) will be considered. Part

Considerations for Mobile Health Technology Developers: Part 1

https://pharmaphorum.com/views-and-analysis/considerations-for-mobile-health-technology-developers-part-1/

Digital/ Views & Analysis/ Views and analysis

The NIH on accelerating research using diverse biomedical datasets

Jessica Hagen All of Us, biomedical research, biosamples, data, diversity, mobile engagement asset, NIH, personalised medicine 0 Comment

Martin Mendoza, PhD, director of health equity and health science policy for the All of Us Research Program

The NIH on accelerating research using diverse biomedical datasets

https://pharmaphorum.com/views-and-analysis/the-nih-on-accelerating-research-using-diverse-biomedical-datasets/

FDA's Brendan O'Leary at DtX East in Boston in 2022

Digital/ News/ News

FDA drops PreCert report, new digital health guidances

Jonah Comstock clinical decision support, DtX East, fda, FDA Pre-Cert Program 0 Comment

The US FDA’s Center for Devices and Radiological Health (CDRH) dropped a bevy of new digital health guidances

FDA drops PreCert report, new digital health guidances

https://pharmaphorum.com/news-digital/fda-drops-precert-report-new-digital-health-guidances/

Global_Kinetics_Personal_Kinetigraph_PKG_Parkinson

Digital/ News/ News/ News/ Patients

NICE backs ‘real-world’ wearable devices for Parkinson’s disease

Phil Taylor digital, digital health, Global Kinetics Corporation, Great Lakes Neurotechnologies, NHS, NICE, Parkinson's disease, patient monitoring, PD Neurotechnology, Sense4Care, wearable 0 Comment

Five wearable devices that monitor patients with Parkinson’s disease as they go about their lives have been given

NICE backs ‘real-world’ wearable devices for Parkinson’s disease

https://pharmaphorum.com/news/nice-backs-real-world-wearable-devices-for-parkinsons-disease/

Digital/ News/ News/ News/ Patients

Better Therapeutics files for FDA approval of diabetes DTx

Phil Taylor Better Therapeutics, Diabetes, digital, digital health, digital therapeutics, regulatory 0 Comment

Digital health company Better Therapeutics has submitted its lead prescription digital therapeutic (DTx) BT-001 to the FDA, seeking

Better Therapeutics files for FDA approval of diabetes DTx

https://pharmaphorum.com/news/better-therapeutics-files-for-fda-approval-of-diabetes-dtx/

1 2 3 4 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Digital

Login